Shandong Jincheng Pharmaceutical Group Co Ltd showcased its innovation and collaboration prowess at the prestigious CPhI Worldwide in Barcelona, Spain.
The event, hosting nearly 2,000 exhibitors and over 65,000 industry professionals, served as a pivotal platform for the pharmaceutical giant to deepen international partnerships.
With a comprehensive display covering pharmaceutical ingredients, finished dosage forms, and biopharmaceuticals, Jincheng Pharma engaged in fruitful exchanges with over 40 foreign enterprises, including industry leaders like Sanofi.
Representatives of the group talk to inquring clients. [Photo provided to shandong.chinadaily.com.cn]
During the exhibition, Jincheng Pharma forged strategic ties with Russian counterparts, fostering mutual learning and potential future collaborations. Face-to-face interactions solidified client perceptions of Jincheng Pharma's brand and cemented commitments for enhanced strategic cooperation.
Looking ahead, Jincheng Pharma remains committed to global expansion, emphasizing agility in meeting clinical demands and market trends. The company aims to fortify its global operational systems while accelerating its international footprint, benefitting a broader spectrum of consumers and stakeholders worldwide.
CPhI Worldwide served as a testament to Jincheng Pharma's dedication to excellence and collaboration in the global landscape. As the company continues to innovate and expand, it positions itself as a leading player in meeting the evolving needs of the global healthcare industry.
